Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,603 | 111,997 | 34,295 | 63,260 | -49,021 |
| Depreciation Amortization | 27 | 1,193 | 884 | 611 | 329 |
| Accounts payable and accrued liabilities | 164 | -1,211 | -1,290 | -860 | -502 |
| Other Working Capital | -6,900 | -4,086 | 17,056 | -10,736 | -2,380 |
| Other Operating Activity | 1,611 | -98,534 | -71,822 | -90,868 | 33,702 |
| Operating Cash Flow | $-8,701 | $9,359 | $-20,877 | $-38,593 | $-17,872 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -21 | -21 | -42 |
| Purchase Sale Intangibles | N/A | -355 | -260 | -267 | -170 |
| Other Investing Activity | 0 | -355 | -260 | -267 | -170 |
| Investing Cash Flow | $N/A | $-355 | $-281 | $-288 | $-212 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,468 | 2,468 | 0 | N/A |
| Other Financing Activity | 0 | -237,674 | -125,729 | -125,000 | -5,000 |
| Financing Cash Flow | $N/A | $-235,206 | $-123,261 | $-125,000 | $-5,000 |
| Beginning Cash Position | 49,317 | 65,122 | 65,122 | 65,122 | 65,122 |
| End Cash Position | 17,248 | 49,317 | 38,330 | 26,303 | 30,384 |
| Net Cash Flow | $-32,069 | $-15,805 | $-26,792 | $-38,819 | $-34,738 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,701 | 9,359 | -20,877 | -38,593 | -17,872 |
| Capital Expenditure | N/A | N/A | -21 | -21 | -42 |
| Free Cash Flow | -8,701 | 9,359 | -20,898 | -38,614 | -17,914 |